MARC A PFEFFER, M.D.
Osteopathic Medicine in Boston, MA
License number
Massachusetts 46266
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
75 Francis Street Brigham & WOMEN'S HOSP, Boston, MA 02115
111 Cypress St, Brookline, MA 02445
111 Cypress St, Brookline, MA 02445
Phone
(617) 732-5681
(857) 307-0896
(857) 307-0896
Personal information
See more information about MARC A PFEFFER at radaris.comName
Address
Phone
29 Colchester St, Brookline, MA 02446
1110 Roxbury Pkwy, Chestnut Hill, MA 02467
71 Fulkerson St, Cambridge, MA 02141
75 Francis St, Waltham, MA 02451
75 Francis St, Boston, MA 02115
Organization information
See more information about MARC A PFEFFER at bizstanding.comMarc Pfeffer
75 Francis St, Boston, MA 02115
Industry:
Medical Doctor's Office
Medical Doctors:
Constance H. Keefer (Medical Doctor),Stacy Melanson (Medical Doctor),David Michael Lee (Medical Doctor),...
Marc Pfeffer MD,PHD
75 Francis St, Boston, MA 02115
Industry:
Cardiologist, Internist
Site:
Phone:
(617) 732-5771 (Phone)
Marc Alan Pfeffer
Marc A Pfeffer MD
75 Francis St, Boston, MA 02115
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Phone:
(617) 732-7139 (Phone)
Products:
Business Law, Personal Law
Professional information
Dr. Marc A Pfeffer, Boston MA - MD (Doctor of Medicine)
Specialties:
Cardiology, Advanced Heart Failure & Transplant Cardiology
Address:
Brigham and Women's Cardiology
75 Francis St, Boston 02115
(857) 307-4000 (Phone)
75 Francis St, Boston 02115
(857) 307-4000 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging
Conditions:
Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypotension, Pulmonary Hypertension, Tricuspid Valve Disease
Certifications:
Advanced Heart Failure and Transplant Cardiology, 2010, Cardiovascular Disease, 1981, Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Brigham and Women's Cardiology
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
University Of Oklahoma College Of Medicine
Graduated: 1976
Peter Bent Brigham Hospital
Graduated: 1977
Graduated: 1979
Graduated: 1980
University Of Oklahoma College Of Medicine
Graduated: 1976
Peter Bent Brigham Hospital
Graduated: 1977
Graduated: 1979
Graduated: 1980
Marc A Pfeffer, Brookline MA
Specialties:
Cardiologist
Address:
111 Cypress St, Brookline, MA 02445
75 Francis St, Boston, MA 02115
75 Francis St, Boston, MA 02115
Education:
University of Oklahoma, College of Medicine - Doctor of Medicine
Brigham & Women's Hospital - Fellowship - Cardiology
Brigham & Women's Hospital - Residency - Family Medicine
Brigham & Women's Hospital - Fellowship - Cardiology
Brigham & Women's Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Advanced Heart Failure and Transplant Cardiology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Methods For Reducing Risk Of Repeat Myocardial Infarction And Increasing Survival In Heart Attack Victims
US Patent:
5977160, Nov 2, 1999
Filed:
Apr 10, 1992
Appl. No.:
7/866827
Inventors:
Marc A. Pfeffer - Chestnut Hill MA
Janice M. Pfeffer - Chestnut Hill MA
Eugene Braunwald - Weston MA
Janice M. Pfeffer - Chestnut Hill MA
Eugene Braunwald - Weston MA
Assignee:
Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61K 3800, A61K 3140, A61K 3178, A61K 3116
US Classification:
514424
Abstract:
The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of an angiotensin converting enzyme inhibitor. The angiotensin converting enzyme inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred angiotensin converting enzyme inhibitor is captopril.
Methods For Reducing Risk Of Repeat Myocardial Infarction And Increasing Survival In Heart Attack Victims
US Patent:
5972990, Oct 26, 1999
Filed:
Nov 25, 1992
Appl. No.:
7/981196
Inventors:
Marc A. Pfeffer - Chestnut Hill MA
Janice M. Pfeffer - Chestnut Hill MA
Eugene Braunwald - Weston MA
Janice M. Pfeffer - Chestnut Hill MA
Eugene Braunwald - Weston MA
Assignee:
Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61K 3800, A61K 3140, A61K 31535
US Classification:
514423
Abstract:
The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.
Methods For Reducing Risk Of Repeat Myocardial Infarction And Increasing Survival In Heart Attack Victims
US Patent:
5952305, Sep 14, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/476661
Inventors:
Marc A. Pfeffer - Chestnut Hill MA
Janice M. Pfeffer - Chestnut Hill MA
Eugene Braunwald - Weston MA
Janice M. Pfeffer - Chestnut Hill MA
Eugene Braunwald - Weston MA
Assignee:
Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61K 3140, A61K 3800, A61K 3154, A61K 3134
US Classification:
514 16
Abstract:
The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.